Efficacy of single and repeated administration of ketamine in unipolar and bipolar depression: a meta-analysis of randomized clinical trials
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy of single and repeated administration of ketamine in unipolar and bipolar depression: a meta-analysis of randomized clinical trials
Authors
Keywords
-
Journal
Pharmacological Reports
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-04-16
DOI
10.1007/s43440-020-00097-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Single and repeated ketamine treatment induces perfusion changes in sensory and limbic networks in major depressive disorder
- (2020) Ashish K. Sahib et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Overlap in the neural circuitry and molecular mechanisms underlying ketamine abuse and its use as an antidepressant
- (2020) Saurabh S. Kokane et al. BEHAVIOURAL BRAIN RESEARCH
- Fast-acting antidepressant activity of ketamine: highlights on brain serotonin, glutamate, and GABA neurotransmission in preclinical studies
- (2019) Thu Ha Pham et al. PHARMACOLOGY & THERAPEUTICS
- Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study
- (2019) Vanina Popova et al. AMERICAN JOURNAL OF PSYCHIATRY
- Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)
- (2019) Maggie Fedgchin et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial
- (2018) Michael F. Grunebaum et al. AMERICAN JOURNAL OF PSYCHIATRY
- The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis
- (2018) Samuel T. Wilkinson et al. AMERICAN JOURNAL OF PSYCHIATRY
- Does oral administration of ketamine accelerate response to treatment in major depressive disorder? Results of a double-blind controlled trial
- (2018) Somaye Arabzadeh et al. JOURNAL OF AFFECTIVE DISORDERS
- Persistent antidepressant effect of low-dose ketamine and activation in the supplementary motor area and anterior cingulate cortex in treatment-resistant depression: A randomized control study
- (2018) Mu-Hong Chen et al. JOURNAL OF AFFECTIVE DISORDERS
- Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects
- (2018) Allison C. Nugent et al. MOLECULAR PSYCHIATRY
- Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
- (2018) Panos Zanos et al. PHARMACOLOGICAL REVIEWS
- Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression
- (2018) Ella J. Daly et al. JAMA Psychiatry
- Repeated oral ketamine for out-patient treatment of resistant depression: randomised, double-blind, placebo-controlled, proof-of-concept study
- (2018) Yoav Domany et al. BRITISH JOURNAL OF PSYCHIATRY
- Cognitive function of patients with treatment-resistant depression after a single low dose of ketamine infusion
- (2018) Mu-Hong Chen et al. JOURNAL OF AFFECTIVE DISORDERS
- Repeat-Dose Ketamine Augmentation for Treatment-Resistant Depression with Chronic Suicidal Ideation: A Randomized, Double Blind, Placebo Controlled Trial
- (2018) Dawn F. Ionescu et al. JOURNAL OF AFFECTIVE DISORDERS
- Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression
- (2018) Wei Zheng et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2018) Spencer L James et al. LANCET
- Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
- (2018) Maurizio Fava et al. MOLECULAR PSYCHIATRY
- Identifying Ketamine Responses in Treatment-Resistant Depression Using a Wearable Forehead EEG
- (2018) Zehong Cao et al. IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING
- Low-dose ketamine for treatment resistant depression in an academic clinical practice setting
- (2017) David Feifel et al. JOURNAL OF AFFECTIVE DISORDERS
- Ketamine for Depression, 4: In What Dose, at What Rate, by What Route, for How Long, and at What Frequency?
- (2017) Chittaranjan Andrade JOURNAL OF CLINICAL PSYCHIATRY
- Oral Ketamine in Treatment-Resistant Depression
- (2017) Maryam I. Al Shirawi et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Dose-Related Effects of Adjunctive Ketamine in Taiwanese Patients with Treatment-Resistant Depression
- (2017) Tung-Ping Su et al. NEUROPSYCHOPHARMACOLOGY
- A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression
- (2016) Jaskaran B. Singh et al. AMERICAN JOURNAL OF PSYCHIATRY
- Ketamine augmentation for outpatients with treatment-resistant depression: Preliminary evidence for two-step intravenous dose escalation
- (2016) Cristina Cusin et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy
- (2016) Marko A. Peltoniemi et al. CLINICAL PHARMACOKINETICS
- KETAMINE FOR TREATMENT-RESISTANT UNIPOLAR AND BIPOLAR MAJOR DEPRESSION: CRITICAL REVIEW AND IMPLICATIONS FOR CLINICAL PRACTICE
- (2016) William V. Bobo et al. DEPRESSION AND ANXIETY
- Comparing the actions of lanicemine and ketamine in depression: key role of the anterior cingulate
- (2016) Darragh Downey et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Efficacy and safety of oral ketamine versus diclofenac to alleviate mild to moderate depression in chronic pain patients: A double-blind, randomized, controlled trial
- (2016) Morteza Jafarinia et al. JOURNAL OF AFFECTIVE DISORDERS
- Continuation phase intravenous ketamine in adults with treatment-resistant depression
- (2016) Jennifer L. Vande Voort et al. JOURNAL OF AFFECTIVE DISORDERS
- Rapid and Sustained Reductions in Current Suicidal Ideation Following Repeated Doses of Intravenous Ketamine
- (2016) Dawn F. Ionescu et al. JOURNAL OF CLINICAL PSYCHIATRY
- A mega-analysis of fixed-dose trials reveals dose-dependency and a rapid onset of action for the antidepressant effect of three selective serotonin reuptake inhibitors
- (2016) F Hieronymus et al. Translational Psychiatry
- The use of ketamine as an antidepressant: a systematic review and meta-analysis
- (2015) Caoimhe M. Coyle et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Effects of Low-Dose and Very Low-Dose Ketamine among Patients with Major Depression: a Systematic Review and Meta-Analysis
- (2015) Ying Xu et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Meta-analysis of short- and mid-term efficacy of ketamine in unipolar and bipolar depression
- (2015) Bruno Romeo et al. PSYCHIATRY RESEARCH
- Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study
- (2015) Y.-D. Hu et al. PSYCHOLOGICAL MEDICINE
- Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial
- (2015) J. W. Murrough et al. PSYCHOLOGICAL MEDICINE
- Ketamine for the Treatment of Depression in Patients Receiving Hospice Care: A Retrospective Medical Record Review of Thirty-One Cases
- (2015) Alana Iglewicz et al. PSYCHOSOMATICS
- A Randomized Controlled Trial of Intranasal Ketamine in Major Depressive Disorder
- (2014) Kyle A.B. Lapidus et al. BIOLOGICAL PSYCHIATRY
- Neurocognitive performance and serial intravenous subanesthetic ketamine in treatment-resistant depression
- (2014) Paulo R. Shiroma et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Do the dissociative side effects of ketamine mediate its antidepressant effects?
- (2014) David A. Luckenbaugh et al. JOURNAL OF AFFECTIVE DISORDERS
- A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes
- (2014) A. McGirr et al. PSYCHOLOGICAL MEDICINE
- Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial
- (2013) James W. Murrough et al. AMERICAN JOURNAL OF PSYCHIATRY
- Neural Correlates of Rapid Antidepressant Response to Ketamine in Treatment-Resistant Unipolar Depression: A Preliminary Positron Emission Tomography Study
- (2013) Paul J. Carlson et al. BIOLOGICAL PSYCHIATRY
- Daily Oral Ketamine for the Treatment of Depression and Anxiety in Patients Receiving Hospice Care: A 28-Day Open-Label Proof-of-Concept Trial
- (2013) Scott A. Irwin et al. JOURNAL OF PALLIATIVE MEDICINE
- Serial infusions of low-dose ketamine for major depression
- (2013) Keith G Rasmussen et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Replication of Ketamine's Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On Trial
- (2012) Carlos A. Zarate et al. BIOLOGICAL PSYCHIATRY
- Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression
- (2012) James W. Murrough et al. BIOLOGICAL PSYCHIATRY
- Star-D: lessons learned and future implications
- (2011) A. John Rush DEPRESSION AND ANXIETY
- Signaling pathways underlying the rapid antidepressant actions of ketamine
- (2011) Ronald S. Duman et al. NEUROPHARMACOLOGY
- A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression
- (2010) Nancy Diazgranados et al. ARCHIVES OF GENERAL PSYCHIATRY
- Oral Ketamine for the Rapid Treatment of Depression and Anxiety in Patients Receiving Hospice Care
- (2010) Scott A. Irwin et al. JOURNAL OF PALLIATIVE MEDICINE
- Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
- (2010) David Moher et al. International Journal of Surgery
- Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression
- (2009) Marije aan het Rot et al. BIOLOGICAL PSYCHIATRY
- Development of a Sublingual/Oral Formulation of Ketamine for Use in Neuropathic Pain
- (2009) Chui Chong et al. CLINICAL DRUG INVESTIGATION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started